Our clinical trials

Our clinical trials aim to demonstrate the clinical utility of circulating tumor cells in the care pathway of cancer patients, using ScreenCell® technology.

Filter by

Type of cancer

Clinical studies registry

Ex Vivo Expansion of Circulating Tumor Cells as a Model for Cancer Predictive Pharmacology (EXPEVIVO-CTC)

Type of cancer:

Mélanoma

Status of the study:

In progress

Promoter:

APHP / Hôpital Saint Louis

Investigative center:

APHP / Hôpital Saint Louis

Evaluation of Circulating Tumor Cells (CTC) Relevance in Breast Cancer Follow-up Using the ScreenCell Device (PROBE-CTC)

Type of cancer:

Breast cancer

Status of the study:

In progress

Promoter:

ScreenCell®

Investigative center:

CMC Ambroise Paré Hartmann

Evaluation of Circulating Tumor Cells (CTCs) by the ScreenCell® device in breast cancer: validation of biomarkers

Type of cancer:

Metastatic breast cancer

Status of the study:

Completed

Promoter:

ScreenCell®

Investigative center:

Laboratoire Dr Kahia Tani

Looking for a simple method for CTC isolation?

You’ve come to the right place!
Fill in the fields below and we’ll take care of the rest.

Our clinical trials

Filter by

Type of cancer

Clinical studies registry

Ex Vivo Expansion of Circulating Tumor Cells as a Model for Cancer Predictive Pharmacology (EXPEVIVO-CTC)

Type of cancer:

Status of the study:

Promoter:

Investigative center:

Evaluation of Circulating Tumor Cells (CTC) Relevance in Breast Cancer Follow-up Using the ScreenCell Device (PROBE-CTC)

Type of cancer:

Status of the study:

Promoter:

Investigative center:

Evaluation of Circulating Tumor Cells (CTCs) by the ScreenCell® device in breast cancer: validation of biomarkers

Type of cancer:

Status of the study:

Promoter:

Investigative center:

Looking for a simple method for CTC isolation?

Upcoming Event

ELBS General Assembly 2025